Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Not Confirmed
Not Confirmed
03-05 January, 2025
Not Confirmed
Not Confirmed
07-09 January, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Pharma, Lab & Chemical...Pharma, Lab & Chemical Expo
Industry Trade Show
Not Confirmed
03-05 January, 2025
Industry Trade Show
Not Confirmed
07-09 January, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/bms-j-j-bayer-lead-25-000-pharma-layoffs-in-2024-amylyx-fibrogen-kronos-bio-hit-by-trial-failures-cash-crunch
25 Mar 2020
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-25-2020-1585131468.pdf
19 Aug 2016
// FDA
https://www.pharmacompass.com/pdf/news/par-form-generic-fluoxetine-hydrochloride-1472292854.pdf
Regulatory Info :
Registration Country : USA
Par Formulations Private Limited
Dosage Form : TABLET; ORAL
Brand Name : EFAVIRENZ
Dosage Strength : 600MG
Packaging :
Approval Date :
Application Number : 202990
Regulatory Info :
Registration Country : USA
RLD :
TE Code :
Par Formulations Private Limited
Dosage Form : TABLET; ORAL
Proprietary Name : EFAVIRENZ
Dosage Strength : 600MG
Approval Date :
Application Number : 202990
RX/OTC/DISCN :
RLD :
TE Code :
Inspections and registrations
District Decision : No Action Indicated
Inspection End Date : 2011-09-21
Par Formulations Private Limited
City : Chennai
State :
Country/Area : IN
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2011-09-21
District Decision : No Action Indicated
Inspection End Date : 2013-10-17
Par Formulations Private Limited
City : Chennai
State :
Country/Area : IN
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2013-10-17
District Decision : No Action Indicated
Inspection End Date : 2015-04-17
Par Formulations Private Limited
City : Chennai
State :
Country/Area : IN
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2015-04-17
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?